Patients should rotate sites, preferred injection sites include the: Abdomen Thigh Upper arm Safety Profile and Adverse Effects to Watch For Common adverse effects mirror those of the GLP-1 receptor agonist class and are primarily gastrointestinal
When clinics advertise "GLP-3 peptide," they're using a nickname for retatrutide that implies a logical progression: GLP-1 leads to GLP-2 leads to GLP-3
Despite their common class, semaglutide is often preferred due to its once-weekly injection schedule and higher average weight loss percentage compared to liraglutides daily regime

Their metabolic health markers, such as blood sugar and cholesterol, also returned to levels similar to those before treatment.(3) Another drawback to taking GLP-1 medications is that while they promote weight loss, recently published research shows that approximately 15% to 60% of the loss comes from lean mass.(5, 6) This is very concerning, because preserving muscle mass is crucial for maintaining metabolic rate, overall health, and functionality as we age.(7) The Potential Solution: A Ketogenic Lifestyle A paper by researchers at Virta Health, published in February 2024, suggests that a ketogenic diet may help people maintain their weight loss after transitioning off GLP-1 medications.(8) The study compared two groups of type 2 diabetes patients following a ketogenic diet: one group continued GLP-1 therapy, and the other group stopped the medication

People who discuss microdosing often describe feeling more involved in dose adjustments, especially when tolerance, lifestyle, or GLP-1 accessibility concerns come into play